chlorambucil has been researched along with azomycin in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kehrberg, G; Moldenhauer, H; Rose, H; Saul, G; Wolf, G | 1 |
Lee, FY; Twentyman, PR; Walton, MI; Workman, P | 1 |
Twentyman, P; Workman, P | 1 |
1 review(s) available for chlorambucil and azomycin
Article | Year |
---|---|
[Intensification of cytostatic action by radiosensitizers--a review of the present status of chemosensitization].
Topics: Alkylating Agents; Animals; Antineoplastic Agents; Chlorambucil; Cisplatin; Cricetinae; Cyclophosphamide; Doxorubicin; Etanidazole; Lomustine; Melphalan; Mice; Misonidazole; Neoplasms, Experimental; Nitroimidazoles; Oxygen; Radiation-Sensitizing Agents | 1984 |
2 other study(ies) available for chlorambucil and azomycin
Article | Year |
---|---|
Drug metabolism and chemosensitization. Nitroimidazoles as inhibitors of drug metabolism.
Topics: Aminopyrine; Animals; Chlorambucil; Female; Kidney Function Tests; Male; Metabolic Clearance Rate; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Nitroimidazoles; Paralysis; Pentobarbital; Pharmaceutical Preparations; Protein Binding; Sleep; Zoxazolamine | 1983 |
Effect of misonidazole or metronidazole pretreatment on the response of the RIF-1 mouse sarcoma to melphalan, cyclophosphamide, chlorambucil and CCNU.
Topics: Animals; Antineoplastic Agents; Cell Survival; Chlorambucil; Cyclophosphamide; Drug Synergism; Drug Therapy, Combination; Female; Lethal Dose 50; Leukocyte Count; Lomustine; Male; Melphalan; Metronidazole; Mice; Mice, Inbred C3H; Misonidazole; Nitroimidazoles; Sarcoma, Experimental | 1982 |